In this study, we first mapped the distribution of ACE2 in different brain regions and then uncovered the altered expression of ACE2 in the AD-pathology brain, which provided fundamental knowledge to understand and manage symptoms of COVID-19 patients in the central nervous system. The gene discussed is ACE2; the disease is COVID-19.